Fuller & Thaler Asset Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
Fuller & Thaler Asset Management's IART Position: Q3 2026 in Review
Fuller & Thaler Asset Management reduced its Integra LifeSciences (IART) stake by 36% in Q3 2026, selling an estimated $21.2M and leaving 2,206,616 shares worth $35.9M. The position accounts for 0.11% of the portfolio, ranked #251.
Fuller & Thaler Asset Management first reported a position in IART in Q2 2019 and has held it in 30 quarters since. The position peaked at $89.2M in Q4 2024. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.
- Fuller & Thaler Asset Management held 2,206,616 shares of Integra LifeSciences worth $35.9M as of Q3 2026.
- Fuller & Thaler Asset Management sold 1,229,390 Integra LifeSciences shares in Q3 2026, an estimated $21.2M.
- Integra LifeSciences made up 0.11% of Fuller & Thaler Asset Management's portfolio in Q3 2026, its #251 holding.
- Fuller & Thaler Asset Management first reported a position in Integra LifeSciences in Q2 2019 and has held it in 30 quarters since.
- Fuller & Thaler Asset Management's Integra LifeSciences position peaked at $89.2M in Q4 2024.
- 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.
Based on Fuller & Thaler Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.